RCS - Agronomics Limited - Agronomics Appoints Comms Consultancy

AgronomicsAnnouncement

14/06/2023 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230614:nRSN6094Ca&default-theme=true

RNS Number : 6094C  Agronomics Limited  14 June 2023

14 June 2023

Agronomics Limited

("Agronomics" or the "Company")

Agronomics Appoints Comms Consultancy for UK and International Brief

 

Agronomics (ANIC:LSE), the leading listed company focused on the field of
cellular agriculture, has appointed SEC Newgate to provide strategic
communications support. The brief, which will encompass both UK and
international media, will focus on building the profile of the business
amongst key investor audiences, as well as increasing awareness of the sector
overall.

The strategic comms, advocacy and insight agency won the retained brief after
a competitive pitch process. SEC Newgate's team will be led by Director Bob
Huxford with support from staff across the agency's Financial Services,
Corporate Reputation and Green & Good teams.

Jim Mellon, Co-Founder and Executive Director at Agronomics, commented:

"Agronomics is at an important stage of growth, so we needed the right
communications partner who could support our journey and fully integrate with
our business strategy. Their team was a standout candidate and clearly
understood how best to leverage the expertise of our spokespeople as well as
boost visibility for our portfolio companies."

Bob Huxford, Director and Senior Advisor for Investor Relations at SEC Newgate
said:

"The sustainable food industry is at an exciting moment in its evolution with
advances being made at breakneck speed. We have a strong track record of
supporting clients in the environmental space and are delighted to be working
with a pioneering business as they transform the global food supply chain."

 

SEC Newgate was recently ranked as a Top 5 ESG Consultancy by PR Week as well
as 12(th) in the PR Week Top 150 Corporate & Financial Consultancies 2023.

 

About Agronomics

Agronomics is a leading listed alternative proteins company with a focus on
cellular agriculture and cultivated meat. The Company has established a
portfolio of over 20 companies in this rapidly advancing sector. It seeks to
secure minority stakes in companies owning technologies with defensible
intellectual property that offer new ways of producing food and materials with
a focus on products historically derived from animals. These technologies are
driving a major disruption in agriculture, offering solutions to improve
sustainability, as well as addressing human health, animal welfare and
environmental damage. This disruption will decouple supply chains from the
environment and animals and be fundamental to feeding the world's expanding
population. A full list of Agronomics' portfolio companies is available at
https://agronomics.im/.

 

About Cellular Agriculture

Cellular Agriculture is the production of agriculture products directly from
cells, as opposed to raising an animal for slaughter or growing crops. This
encompasses cell culture to produce cultivated meat and materials, and
fermentation processes that harness a combination of molecular biology,
synthetic biology, tissue engineering and biotechnology to massively simplify
production methods in a sustainable manner.

 

Over the coming decades, the source of the world's food supply traditionally
derived from conventional agriculture is going to change dramatically. We have
already witnessed the first wave of this shift with the consumer adoption of
plant-based alternative proteins but today, we are on the cusp of an even
bigger wave of change. This is being facilitated by advances in cellular
agriculture. This change is necessary, given scientists' claims that if we
maintain existing animal protein consumption patterns, then we will not meet
the Paris Agreement's goal of limiting warming to 1.5℃.

 

AT Kearney, a global consultancy firm, projects that cultivated meat's market
share will reach 35% by 2040. This combined with the Good Food Institute's
estimate that a US $1.8 trillion investment will be required in order to
produce just 10% of the world's protein using this technology, means that we
are on the cusp of a multi-decade flow of capital to build out manufacturing
facilities. Funding in the field of cellular agriculture is accelerating,
however, still, less than US$ 5 billion has been invested worldwide since the
industry's inception in 2016.

For further information please contact:

 

 Agronomics                                       Beaumont              Canaccord Genuity Limited        Cenkos                Peterhouse Capital    SEC Newgate

 Limited                                          Cornish Limited                                        Securities Plc        Limited
 The Company                                      Nomad                 Joint Broker                     Joint Broker          Joint Broker          Financial Communications
 Richard Reed                                     Roland Cornish        Andrew Potts                     Giles Balleny         Lucy Williams         Bob Huxford

 Denham Eke                                       James Biddle          Harry Rees                       Michael Johnson       Charles Goodfellow    George Esmond

                                                                        Alex Aylen (Head of Equities)
 +44 (0) 1624 639396                              +44 (0) 207 628 3396  +44 (0) 207 523 8000             +44 (0) 207 397 8900  +44 (0) 207 469 0936  Agronomics@secnewgate.co.uk

 info@agronomics.im (mailto:info@agronomics.im)

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NRADXLFFXQLBBBV